EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACU and the CUSIP is G3167F110. A total of 62 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,014 | -99.9% | 200,000 | -2.5% | 0.00% | 0.0% |
| Q3 2022 | $2,033,000 | +1.5% | 205,190 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,003,000 | -0.9% | 205,190 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,021,000 | -70.5% | 205,190 | -70.3% | 0.00% | -66.7% |
| Q4 2021 | $6,848,000 | -0.7% | 690,958 | -0.4% | 0.00% | -25.0% |
| Q3 2021 | $6,893,000 | -2.5% | 693,500 | -2.0% | 0.00% | 0.0% |
| Q2 2021 | $7,069,000 | -19.3% | 707,632 | -18.7% | 0.00% | -33.3% |
| Q1 2021 | $8,757,000 | – | 870,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Exos Asset Management LLC | 50,000 | $502,000 | 0.39% |
| Arena Capital Advisors, LLC- CA | 300,000 | $3,020,000 | 0.30% |
| MMCAP International Inc. SPC | 250,000 | $2,516,000 | 0.25% |
| PERISCOPE CAPITAL INC. | 350,000 | $3,523,000 | 0.14% |
| Kepos Capital LP | 175,000 | $1,761,000 | 0.11% |
| Ghisallo Capital Management LLC | 150,000 | $1,508,000 | 0.10% |
| Shaolin Capital Management LLC | 200,000 | $2,013,000 | 0.08% |
| Atalaya Capital Management LP | 40,000 | $402,000 | 0.08% |
| Radcliffe Capital Management, L.P. | 200,000 | $2,013,000 | 0.08% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 57,789 | $581,000 | 0.07% |